Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients

Summary

This study is being conducted to determine whether MAU868 warrants further clinical development for the prevention of BKV infection in kidney transplant recipients.

Timeline

Start

2018-10-15

Primary completion

2020-07-13

Completion

2020-11-16

Outcome

Outcome not reported

Stopped: “company decision”

Drugs

Indications